| 摘要: |
| mRNA技术已经成为生物医学领域的革命性技术,特别是在新冠大流行期间,mRNA疫苗极大降低了重症的发生率和死亡率。然而,随着该技术在临床治疗中的日益普及,安全性问题逐渐成为研究和应用的焦点,尤其是关于潜在毒性风险的管理与解决策略。随着mRNA技术在临床应用范围的不断扩大,迫切需要解决这些安全性挑战,以保障mRNA技术的长期可持续发展。本综述介绍了mRNA药物组分的致炎机制,展望了提升mRNA药物安全性的途径。 |
| 关键词: mRNA药物 脂质纳米颗粒 可电离脂质 炎症反应 |
| DOI:10.13506/j.cnki.jpr.2025.09.012 |
| 基金项目:国家自然科学基金项目(No.32471004) |
|
Publication Date:September 25, 2025
|
|
| Research progress of the safety and toxicity of mRNA-LNP drugs |
| CAI Yunjie1,2,LIN Ang1,2 |
| (1. School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing 211198,China;2. Center for New Drug Safety Evaluation and Research, China Pharmaceutical University, Nanjing 211198,China) |
| Abstract: |
| mRNA technology has become a revolutionary technique in the biomedical field, especially during the COVID-19 pandemic when SARS-CoV-2 mRNA vaccines were widely used and largely helped to mitigate disease burden globally. However, with continuous expansion of the clinical applications of mRNA technology, its safety issues have caused major concerns and urged management of potential toxicity risks. In this concise review, we summarize current studies on the induction of undesired inflammation by mRNA drug formulations, and further discussed potential approaches that can be utilized to tackle this challenge. |
| Key words: mRNA drug Lipid nanoparticle Ionizable lipid Inflammatory responses |